Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neuropharmacology
2020 Aug 15;173:107971. doi: 10.1016/j.neuropharm.2020.107971.
Show Gene links
Show Anatomy links
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
Yi F, Rouzbeh N, Hansen KB, Xu Y, Fanger CM, Gordon E, Paschetto K, Menniti FS, Volkmann RA.
???displayArticle.abstract???
NMDA receptors are ionotropic glutamate receptors that mediate excitatory neurotransmission. The diverse functions of these receptors are tuned by deploying different combinations of GluN1 and GluN2 subunits (GluN2A-D) to form either diheteromeric NMDA receptors, which contain two GluN1 and two identical GluN2 subunits, or triheteromeric NMDA receptors, which contain two GluN1 and two distinct GluN2 subunits. Here, we characterize PTC-174, a novel positive allosteric modulator (PAM) of receptors containing GluN2C or GluN2D subunits. PTC-174 potentiates maximal current amplitudes by 1.8-fold for diheteromeric GluN1/2B receptors and by > 10-fold for GluN1/2C and GluN1/2D receptors. PTC-174 also potentiates responses from triheteromeric GluN1/2B/2D and GluN1/2A/2C receptors by 4.5-fold and 1.7-fold, respectively. By contrast, PTC-174 produces partial inhibition of responses from diheteromeric GluN1/2A and triheteromeric GluN1/2A/2B receptors. PTC-174 increases potencies of co-agonists glutamate and glycine by 2- to 5-fold at GluN1/2C and GluN1/2D receptors, and NMDA receptor activation facilitates allosteric modulation by PTC-174. At native NMDA receptors in GluN2D-expressing subthalamic nucleus neurons, PTC-174 increases the amplitude of responses to NMDA application and slows the decay of excitatory postsynaptic currents (EPSCs) evoked by internal capsule stimulation. Furthermore, PTC-174 increases the amplitude and slows the decay of EPSCs in hippocampal interneurons, but has not effect on the amplitudes of NMDA receptor-mediated EPSCs in hippocampal CA1 pyramidal neurons. Thus, PTC-174 provides a useful new pharmacological tool to investigate the molecular pharmacology and physiology of GluN2C- and GluN2D-containing NMDA receptors.
Acker,
Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.
2013, Pubmed
Acker,
Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.
2013,
Pubmed Acker,
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
2011,
Pubmed Alsaad,
In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.
2019,
Pubmed Baufreton,
Sparse but selective and potent synaptic transmission from the globus pallidus to the subthalamic nucleus.
2009,
Pubmed Benveniste,
Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine.
1991,
Pubmed Berman,
Antidepressant effects of ketamine in depressed patients.
2000,
Pubmed Bhattacharya,
Triheteromeric GluN1/GluN2A/GluN2C NMDARs with Unique Single-Channel Properties Are the Dominant Receptor Population in Cerebellar Granule Cells.
2018,
Pubmed
,
Xenbase Bischofberger,
Patch-clamp recording from mossy fiber terminals in hippocampal slices.
2006,
Pubmed Brickley,
NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites.
2003,
Pubmed Brothwell,
NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones.
2008,
Pubmed Chenard,
Antagonists selective for NMDA receptors containing the NR2B subunit.
1999,
Pubmed Citri,
Synaptic plasticity: multiple forms, functions, and mechanisms.
2008,
Pubmed Clements,
Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor.
1991,
Pubmed Costa,
A novel family of negative and positive allosteric modulators of NMDA receptors.
2010,
Pubmed
,
Xenbase Cull-Candy,
NMDA receptor subunits: diversity, development and disease.
2001,
Pubmed Cull-Candy,
Role of distinct NMDA receptor subtypes at central synapses.
2004,
Pubmed Dore,
The Emergence of NMDA Receptor Metabotropic Function: Insights from Imaging.
2016,
Pubmed Dravid,
Activation of recombinant NR1/NR2C NMDA receptors.
2008,
Pubmed Durand,
Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C.
1992,
Pubmed
,
Xenbase Farrant,
NMDA-receptor channel diversity in the developing cerebellum.
1994,
Pubmed Feng,
Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.
2004,
Pubmed
,
Xenbase Forman,
Openspritzer: an open hardware pressure ejection system for reliably delivering picolitre volumes.
2017,
Pubmed Glasgow,
Molecular bases of NMDA receptor subtype-dependent properties.
2015,
Pubmed Gray,
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo.
2011,
Pubmed Hackos,
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
2016,
Pubmed Hagino,
Essential role of NMDA receptor channel ε4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine.
2010,
Pubmed Hansen,
Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists.
2010,
Pubmed
,
Xenbase Hansen,
Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
2014,
Pubmed
,
Xenbase Hansen,
Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase Hansen,
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
2011,
Pubmed
,
Xenbase Hansen,
NMDA Receptors in the Central Nervous System.
2017,
Pubmed Hatton,
Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
2005,
Pubmed
,
Xenbase Herman,
Extracellular glutamate concentration in hippocampal slice.
2007,
Pubmed Hildebrand,
GluN2B and GluN2D NMDARs dominate synaptic responses in the adult spinal cord.
2014,
Pubmed Hollmann,
Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.
1993,
Pubmed
,
Xenbase Ishii,
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
1993,
Pubmed
,
Xenbase Jones,
Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones.
2005,
Pubmed Karakas,
Crystal structure of a heterotetrameric NMDA receptor ion channel.
2014,
Pubmed Karavanova,
Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice.
2007,
Pubmed Khatri,
Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
2014,
Pubmed
,
Xenbase Kleckner,
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase Layton,
Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists.
2006,
Pubmed Lee,
NMDA receptor structures reveal subunit arrangement and pore architecture.
2014,
Pubmed
,
Xenbase Luo,
The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B).
1997,
Pubmed Magill,
Synchronous unit activity and local field potentials evoked in the subthalamic nucleus by cortical stimulation.
2004,
Pubmed Malenka,
LTP and LTD: an embarrassment of riches.
2004,
Pubmed Misra,
Identification of subunits contributing to synaptic and extrasynaptic NMDA receptors in Golgi cells of the rat cerebellum.
2000,
Pubmed Monaghan,
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
2012,
Pubmed Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed Mosley,
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
2010,
Pubmed
,
Xenbase Mullasseril,
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
2010,
Pubmed Nagy,
Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.
2016,
Pubmed Nakanishi,
Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors.
1992,
Pubmed
,
Xenbase Niciu,
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
2014,
Pubmed Nutt,
Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism.
2008,
Pubmed Paoletti,
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
2013,
Pubmed Perszyk,
GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.
2016,
Pubmed
,
Xenbase Preskorn,
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
2008,
Pubmed Rauner,
Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses.
2011,
Pubmed Sanacora,
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
2017,
Pubmed Santangelo Freel,
Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase Sheng,
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex.
1994,
Pubmed Soares,
A prominent role for triheteromeric GluN1/GluN2A/GluN2B NMDARs at central synapses.
2013,
Pubmed Standaert,
Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.
1994,
Pubmed Sugihara,
Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing.
1992,
Pubmed
,
Xenbase Swanger,
A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
2018,
Pubmed
,
Xenbase Swanger,
NMDA Receptors Containing the GluN2D Subunit Control Neuronal Function in the Subthalamic Nucleus.
2015,
Pubmed Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed Vance,
GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
2012,
Pubmed
,
Xenbase Van Dongen,
Presynaptic NMDA Receptors
2009,
Pubmed Volkmann,
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit.
2016,
Pubmed
,
Xenbase von Engelhardt,
GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice.
2015,
Pubmed Williams,
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
1993,
Pubmed
,
Xenbase Yamasaki,
Opposing role of NMDA receptor GluN2B and GluN2D in somatosensory development and maturation.
2014,
Pubmed Yamawaki,
Frequency selectivity and dopamine-dependence of plasticity at glutamatergic synapses in the subthalamic nucleus.
2012,
Pubmed Yi,
Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
2016,
Pubmed
,
Xenbase Yi,
Properties of Triheteromeric N-Methyl-d-Aspartate Receptors Containing Two Distinct GluN1 Isoforms.
2018,
Pubmed
,
Xenbase Yi,
Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
2019,
Pubmed Yuan,
Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
2009,
Pubmed
,
Xenbase Zarate,
A double-blind, placebo-controlled study of memantine in the treatment of major depression.
2006,
Pubmed Zhang,
Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors.
2015,
Pubmed Zhang,
GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease.
2014,
Pubmed Zimmerman,
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
2014,
Pubmed
,
Xenbase Zukin,
Alternatively spliced isoforms of the NMDARI receptor subunit.
1995,
Pubmed
